dibrompropamidine

This page covers all dibrompropamidine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Suppressor of tumorigenicity 14 protein, Urokinase-type plasminogen activator, Prothrombin.

Targets

Suppressor of tumorigenicity 14 protein, Urokinase-type plasminogen activator, Prothrombin

Phase 2 pipeline (1)

• Dibromopropamidine · Oncology
  Dibromopropamidine works by binding to the Suppressor of tumorigenicity 14 protein, potentially inhibiting its activity.

Patent intelligence

• dibrompropamidine patent landscape — aggregated cliff calendar, attackable patents, originator estates